In vivo tissue-specific regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists

Virology

Volumn 294, Issue 1, 2002, Pages 135-140

  Morales Peza, Néstor ^a   Auewarakul, Prasert ^b   Juárez, Victoria ^c   García Carrancá, Alejandro ^a,d   Cid Arregui, Angel ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Cervical cancer; Estrogen; Gene expression; LCR; Oncogenic HPV; Progesterone; Receptor; RU486; Tamoxifen

Indexed keywords

BETA GALACTOSIDASE; ESTROGEN; MIFEPRISTONE; PROGESTERONE; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; VAGINA; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS; PAPILLOMAVIRUS;

EID: 0036067972     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1287     Document Type: Article

References (29)

1. Glucocorticoid receptor expression during the development of the embryonic mouse secondary palate
2. Intracellular localization and trafficking of steroid receptors
3. Long-term use of oral contraceptives and risk of invasive cervical cancer
4. Parity as a risk factor for cervical cancer
5. Endocrinological changes of pregnancy
6. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia
7. Cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region in transgenic mice and its modulation by tetradecanoyl phorbol acetate and glucocorticoids
8. Transgenic mouse strategies in virus research
9. The laboratory mouse
10. The ovarian cycle of the rat
11. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18
12. A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat
13. Physiological action of progesterone in target tissues
14. Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association
15. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers
16. Inhibitory cross-talk between steroid hormone receptors: Differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors
17. A specific progesterone receptor in the hamster uterus: Physiologic properties and regulation during the estrous cycle
18. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
19. Regulation of human papillomavirus type 18 in vivo: Effects of estrogen and progesterone in transgenic mice
20. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells
21. Bacterial β-galactosidase as a marker of Rous sarcoma virus gene expression and replication
22. Progesterone receptor repression by estrogens in rat uterine epithelial cells
23. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses
24. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
25. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
26. Histochemistry and cytochemistry of nuclear receptors
27. Papillomavirus infections - A major cause of human cancers
28. Human papillomaviruses